IDH1 and brain neoplasm: One such metabolite is D-2-hydroxyglurate (D-2HG), the concentration of which is very low in healthy individuals, but high in subsets of leukaemias and brain tumours that harbour gain of function mutations of the enzymes isocitrate dehydrogenase 1 or 2 (IDH1 or 2)11.